Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 31 Issue 12, December 2013

Artistic rendition of hyperbranched amplicons created by multiple-displacement amplification. Gole et al. uniformly amplify the DNA of single cells in nanoliter wells, enabling copynumber variants to be detected in primary human neurons (p 1126). Credit: Kun Zhang

Editorial

  • Moves to give biosimilars nonproprietary names different from brand products are more than a wrangle about words—they could mean biosimilars arrive stillborn to the market.

    Editorial

    Advertisement

Top of page ⤴

News

Top of page ⤴

Correction

Top of page ⤴

News

Top of page ⤴

News Feature

  • How long will the investor exuberance driving public offerings of biotech companies last? Brady Huggett investigates.

    • Brady Huggett
    News Feature
Top of page ⤴

Bioentrepreneur

Top of page ⤴

Correspondence

Top of page ⤴

Patents

Top of page ⤴

News & Views

  • Combining genotyping and the data locked in medical records yields a large number of known genotype-phenotype associations.

    • Nigam H Shah
    News & Views
  • Technologies developed for genome editing are repurposed to study functions of chromatin modifications.

    • Philipp Voigt
    • Danny Reinberg
    News & Views
Top of page ⤴

Analysis

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Erratum

Top of page ⤴

Corrigendum

Top of page ⤴

Careers and Recruitment

  • The current academic culture needs to change its mission, which is narrowly focused on training PhDs to be the next generation of academic tenure-track scientists.

    • Nathan L Vanderford
    Careers and Recruitment
  • Careers and Recruitment
Top of page ⤴

Search

Quick links